NRXS

アフターアワーズ： 7.05 0.05 +0.71%

Neuraxis Inc (NRXS)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Neuraxis Inc Stock (NRXS) Company Profile

Neuraxis Inc

Healthcare (1111)

Biotechnology (621)

(812) 689-0791

11550 North Meridian Street, Suite 325, Carmel

NRXS's Discussions on Twitter

Compare NRXS vs VRTX, REGN, ARGX, ALNY, RVMD

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
NRXS Neuraxis Inc	7.00	91.40M	3.57M	-7.80M	-6.56M	-0.9703
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Neuraxis Inc (NRXS) 最新ニュース

Neuraxis Inc (NRXS) 財務データ

Neuraxis Inc (NRXS)

Neuraxis Inc Stock (NRXS) Company Profile

Compare NRXS vs VRTX, REGN, ARGX, ALNY, RVMD

Neuraxis Inc (NRXS) 最新ニュース

Neuraxis Inc. (NRXS) Holds Near Support After Marginal DeclineMA Cross Alert - Newser

Neuraxis Inc. (NRXS) Q1 2026 Earnings: Narrower Loss Beats Estimates, but Stock Slips on Pre‑Revenue Concerns - Newser

NeurAxis Earnings Call Highlights Growth and Hurdles - TipRanks

Minot Light Capital Fund Drops 2.7 Percent Amid Sector Rotation - HarianBasis.co

NeurAxis (NRXS) Climbs on Reimbursement and Guideline Momentum - Insider Monkey

Neuraxis (NRXS) Stock Analysis: -5.84% Loss — Key Levels 2026-05-18Stock Idea Hub - Newser

NeurAxis slides 21%, raises $5M via stock - MSN

The surprise hidden in Neuraxis NRXS last earnings report Q4 2025 Earnings Beat EstimatesCrowd Verified Signals - Newser

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y - Yahoo Finance

NeurAxis revenues up 80% to USD 1.6M in Q1 2026 - Medical Buyer

Craig-Hallum Sticks to Its Buy Rating for NeurAxis, Inc. (NRXS) - The Globe and Mail

TradingKey - TradingKey

NeurAxis signals burn rate of $1M or less for rest of 2026 while targeting ~ $15M revenue for cash flow breakeven - MSN

Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges - Investing.com Canada

Earnings call transcript: Neuraxis Q1 2026 sees record revenue growth - Investing.com

Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga

NRXS: Q1 2026 revenue up 80% year-over-year, with margin and adoption gains in covered markets - TradingView

NeurAxis, Inc. Reports 80% Revenue Growth in Q1 2026 Driven by CPT Code Assignment and Expanded Product Adoption - Quiver Quantitative

Neuraxis, INC 1Q 2026: Revenue $1.61M, EPS $(0.18) — 10-Q Summary - TradingView

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth - GlobeNewswire

NeurAxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat EstimatesCommunity Risk Signals - newser.com

Neuraxis | ARS: Annual Report to Security Holders - Moomoo

NeurAxis (NRXS) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08Open Stock Picks - newser.com

Number of shareholders of Neuraxis, Inc. – AMEX:NRXS - TradingView

NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat.CFO Commentary - newser.com

The critical factors shaping Neuraxis (NRXS) future (Technical Weakness) 2026-05-08Retail Trader Ideas - newser.com

This Small-Cap Healthcare Stock Is Up 300% in a Year and Is Quickly Gaining a Following - inkl

NeurAxis will post first-quarter results before market open May 12 - Stock Titan

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 - GlobeNewswire

The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis - Yahoo Finance

Top stock reports for Alphabet, Walmart & Micron - MSN

Bigger Capital, Michael Bigger report NRXS holdings (NRXS) and warrant limits - Stock Titan

Neuraxis | SCHEDULE 13G/A: Others - Moomoo

Neuraxis (NRXS) director Gil reports stock awards from Series B dividend - Stock Titan

Neuraxis | 4: Statement of changes in beneficial ownership of securities-Director Aharon Gil - Moomoo

NeurAxis (NRXS) price target increased by 29.41% to 11.22 - MSN

NRXS Ownership | NEURAXIS INC (NYSEARCA:NRXS) - ChartMill

Neuraxis (NRXS) asks investors to expand 2022 stock plan and approve ESPP - Stock Titan

Neuraxis | DEF 14A: Definitive information statements - Moomoo

NeurAxis (NRXS) price target increased by 21.43% to 8.67 - MSN

NeurAxis (NASDAQ:NRXS) Trading Up 5.5%Here's What Happened - MarketBeat

NRXS Should I Buy - Intellectia AI

NeurAxis Expands At-The-Market Equity Offering Capacity - The Globe and Mail

Neuraxis increases at-the-market offering capacity to $11.5 million on NYSE American - Investing.com India

Neuraxis increases ATM capacity to $11.5M after $6.27M program sales - TradingView

Neuraxis (NRXS) boosts at-the-market share sale capacity to $11.5M - Stock Titan

Neuraxis, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Trading Information (April 21, 2026) 345726 - Minichart

NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum - ChartMill

1.25 million more people gain access to NeurAxis' IBS pain device - Stock Titan

Neuraxis Inc (NRXS) 財務データ

収益

当期純利益

現金流量

EPS

NRXSに似た銘柄